• Harmony Biosciences Chief Medical Officer Budur Kumar cut his stake to 13,115 common shares in transactions dated Sept. 4-8.
• Disposed of 33,954 shares at weighted-average prices of USD 41.98 to USD 43.1 per share.
• Exercised stock options for 22,954 shares at USD 30.69 and USD 30.27 per share.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harmony Biosciences Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002009762-26-000005), on September 09, 2026, and is solely responsible for the information contained therein.